Clinical trial
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in…
NCT00263718 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00263718 |
|---|---|
| Title | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris |
| Official title | Calcipotriol Plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle Alone in Psoriasis Vulgaris |
| Lead sponsor | LEO Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis Vulgaris |
| Intervention type | Drug |
| Interventions | Calcipotriol plus betamethasone dipropionate (LEO 80185) gel |
| Enrollment | 360 |
| Start date | Dec 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Dec 9, 2005 |
| Last update posted | Feb 24, 2025 |
| Countries | Canada, Germany, Ireland, Sweden, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: